The Division of Pediatrics Diabetes and Endocrinology is known for its exemplary educational program and research efforts.
Our mission is to improve the health of all diabetes and endocrinology patients — especially children in Missouri — through patient-centered care.
Our History
Robert L. Jackson, MD, served as the first Chief of Pediatrics Endocrinology at the MU School of Medicine. He emphasized how controlling blood sugars in Type 1 diabetes would help prevent complications. At the time, Dr. Jackson’s views were unconventional — yet they eventually resulted in the Diabetes Control and Complications Trial (DCCT) as well as him receiving the Banting Award, which is the highest award from the American Diabetes Association.
David Goldstein, MD, was the second chief of our division. His contribution to the diabetes field was the development of the HbA1c with Randy Little, PhD, and Jack London. The University of Missouri pathology lab sets the standard nationally and internationally for the HbA1c. Dr. Goldstein also participated in the DCCT trial as well as its follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC).
Today, Soumya Kattikat, MD, serves as the fourth Chief of Pediatrics Endocrinology.
Find information for patients.
